101 related articles for article (PubMed ID: 1000549)
1. [Significance of CEA (carcinoembryonic antigen) level determination in patients with malignant tumours (author's transl)].
Kimlová I; Matĕjková E
Cas Lek Cesk; 1976 Nov; 115(45):1397-8. PubMed ID: 1000549
[No Abstract] [Full Text] [Related]
2. [Immunodiagnostics of malignant tumours (author's transl)].
Bubeník J
Cas Lek Cesk; 1974; 113(12):358-60. PubMed ID: 4132894
[No Abstract] [Full Text] [Related]
3. [Solubilisation of the carcinoembryonic antigen (CEA) from a plasma membrane fraction isolated from the cancerous human gastric mucosa (author's transl)].
Bara J; von Kleist S; Burtin P
Ann Immunol (Paris); 1974 Nov; 125(6):939-46. PubMed ID: 4466446
[No Abstract] [Full Text] [Related]
4. [Serial determination of carcinoembryonic antigen in the follow-up of patients with malignant tumours (author's transl)].
Eimermacher H; Schuster P; Beyer HK
Dtsch Med Wochenschr; 1981 Apr; 106(14):428-30. PubMed ID: 7215166
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen (CEA): a review and current status.
Blundell GP
Med Ann Dist Columbia; 1973 May; 42(5):222-4. PubMed ID: 4512988
[No Abstract] [Full Text] [Related]
6. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
Niwa Y; Shimokata K
Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of serum CEA level in various malignant tumors (author's transl)].
Kinoshita F; Maekawa A; Baba R; Horiuchi K; Nishikawa M; Watanabe M; Okada K; Kamiyama I; Yano S; Hashimoto K; Yatomi K; Ogasawara T; Nakagawa T; Okada R; Nagai M
Rinsho Hoshasen; 1978 Feb; 23(2):239-49. PubMed ID: 344947
[No Abstract] [Full Text] [Related]
8. [Significance of the radioimmunologic determination of carcinoembryonic antigen in the diagnosis and course control of malignant tumors].
Neumeier D; Wolter B; Fateh-Moghadam A; Knedel M
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1747-50. PubMed ID: 1030098
[No Abstract] [Full Text] [Related]
9. [Clinical significance of CEA determination in the diagnosis of pancreatic carcinoma].
Neumeier D; Glück B; Fateh-Moghadam A; Knedel M
Z Gastroenterol Verh; 1976; (11):95-6. PubMed ID: 65872
[No Abstract] [Full Text] [Related]
10. [Methodical accomplishment and results of quality control attempts in the CEA determination using a commercial radioimmunoassay kit].
Neumeier D; Glück B; Fateh-Moghadam A; Knedel M
Z Gastroenterol Verh; 1976; (11):71-2. PubMed ID: 65867
[No Abstract] [Full Text] [Related]
11. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
Matsuoka Y; Kuroki M; Koga Y; Kuriyama H; Mori T; Kosaki G
Cancer Res; 1982 May; 42(5):2012-8. PubMed ID: 6175402
[TBL] [Abstract][Full Text] [Related]
12. [Oncofetal proteins - their character and clinical significance as tumour-markers (author's transl)].
Ziegenbein R
Zentralbl Chir; 1980; 105(23):1537-45. PubMed ID: 6163265
[TBL] [Abstract][Full Text] [Related]
13. [Immunology of cancer: basic experiments and clinical progress (author's transl)].
Pasternak G
Arch Geschwulstforsch; 1973; 42(4):345-57. PubMed ID: 4138903
[No Abstract] [Full Text] [Related]
14. [Purification of carcinoembryonic antigen (CEA) employing polyacrylamide gel electrophoresis (author's transl)].
Ishikawa N
Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Feb; 39(2):113-9. PubMed ID: 450647
[No Abstract] [Full Text] [Related]
15. [Tumor-immunologic phenomena: theoretic principles, clinical importance].
Gallmeier WM
Fortschr Geb Rontgenstr Nuklearmed; 1973; 0(0):suppl:298-9. PubMed ID: 4135302
[No Abstract] [Full Text] [Related]
16. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers].
Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L
Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen (CEA) and gastrointestinal cancer associated antigen CA 19-9 in bronchioloalveolar carcinomas and pulmonary adenocarcinomas.
Heikkilä L; Suomalainen RJ; Lindgren J; Jalanko H; Harjula A; Mattila S
Ann Chir Gynaecol; 1986; 75(5):260-5. PubMed ID: 3030184
[TBL] [Abstract][Full Text] [Related]
18. [Derepression phenomenons and onco-fetal proteins].
Kühn RA
Z Gesamte Inn Med; 1974 Nov; 29(21):870-3. PubMed ID: 4462340
[No Abstract] [Full Text] [Related]
19. [Immunologic diagnosis of malignant processes. Clinical significance].
Gil Extremera B
Rev Clin Esp; 1978 Jan; 148(1):1-11. PubMed ID: 635245
[No Abstract] [Full Text] [Related]
20. [CEA determination in tobacco smokers as a prophylactic factor (author's transl)].
Becalski J; Czerwińska A; Woy-Wojciechowski J
Pol Przegl Radiol Med Nukl; 1979; 43(5):313-5. PubMed ID: 542408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
